As of 2025-10-20, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 43.95 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -75.9%.
The range of the Relative Valuation is 31.41 - 50.87 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 16.5x | 15.8x |
| Forward P/E multiples | 12.1x - 18.8x | 15.2x |
| Fair Price | 31.41 - 50.87 | 43.95 |
| Upside | -82.8% - -72.1% | -75.9% |
| Date | P/E |